A “genomic-first” approach to screening for rare genetic disorders—identifying specific genetic variants and then studying associated traits and symptoms—can identify these conditions earlier and more frequently than standard genetic testing driven by clinical symptoms, a Geisinger study found.
This article was originally published on MedicalXpress.com